Agilent Technologies Income Statement (Annual) Export Data. Agilent’s management will present additional details regarding the company’s first-quarter 2020 financial results on a conference call with investors today at 1:30 p.m. PST. The company generated revenues of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. 2015 Proxy Statement. By providing your email address below, you are providing consent to Agilent to send you the requested Investor Email Alert updates. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. Published: February 4, 2021. The book covers: A step-by-step TPM program as implemented at a major US corporation The 5-why analysis method Examples of one-point lessons Using visual controls in a TPM program Tools for understanding equipment failures Improving machine ... Information about Agilent is available at www.agilent.com. Now in its 20th year delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people … About. Agilent expects second-quarter 2020 revenue in the range of $1.28 billion to $1.32 billion. DGG’s operating margin was 13.5%. Analysts covering Agilent Technologies Inc currently have a consensus Earnings Per Share (EPS) forecast of 4.311 for the next financial year. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent’s revenue and non-GAAP earnings guidance for the second quarter and full fiscal year 2020, the impact of coronavirus disease 2019 (COVID-19) and future amortization of intangibles. The global measuring and control instruments market is expected to grow from $702.51 billion in 2020 to $750.62 billion in 2021 at a compound annual … Therefore, no reconciliation to GAAP amounts has been provided for the projection. On-demand continuing education. Income from operations of our reporting segments exclude, among other things, charges related to amortization of intangibles, transformational initiatives, acquisition and integration costs, and NASD site costs. In this book, David Packard tells the simple yet extraordinary story of his life's work and of the truly exceptional company that he and Bill Hewlett started in a garage 55 years ago. To receive the latest Agilent news, subscribe to the Agilent Newsroom. If you experience any issues with this process, please contact us for further assistance. Research and development expenses decreased due to the shutdown of our sequencer development program and a reduction in discretionary expenditures including travel costs. Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core (1) basis). Agilent Releases 2019 Corporate Social Responsibility Report. Investor Relations. Agilent Technologies, Inc. (NYSE: A) today issued its 21st annual Corporate Social Responsibility (CSR) report. Note: We will update this report at most every month or at least every quarter (there can be exceptions). Do NOT follow this link! 'Agilent's mission is to provide trusted answers and insights that advance the quality of life. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Hoffmann La Roche Ltd,Illumina Inc.,Life Technologies Corporation,LC Life sciences LLC,Qiagen N V,Sigma Aldrich Corporation,Thermo Fisher Scientific ... annual reports, and journals. At Agilent, we promise to treat your data with respect and will not share your information with any third party. An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made and if different estimates that reasonably could have been used or changes in the accounting estimate that are reasonably likely to occur could materially change the financial statements. Drug Code. Written by the prizewinning reporter who broke the story in The Wall Street Journal, The Greatest Trade Ever is a superbly written, fast-paced, behind-the-scenes narrative of how a contrarian foresaw an escalating financial crisis--that ... (3) Non-GAAP earnings per share as projected for Q2 FY20 and full fiscal year 2020 excludes primarily the impacts of non-cash intangibles amortization, transformational initiatives, acquisition and integration costs, Nucleic Acid Solutions Division (“NASD”) site costs and mergers and acquisitions announced but not closed. Additional financial information can be found at www.investor.agilent.com by selecting “Financial Results” in the “Financial Information” section. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.26 billion for the third quarter ended July 31, 2020, a decline of 1% compared to the third quarter of 2019 and down 3.1% on a core (1) basis. As Chief Executive Officer at AGILENT TECHNOLOGIES INC, Michael R. McMullen made $13,610,481 in total compensation. Global life sciences and diagnostics company advances environmental goals; invests more than $5M in sustainability-focused initiatives Agilent Technologies Inc. (NYSE: A) today launched its 19 th annual Corporate Social Responsibility (CSR) report, highlighting innovations and advancements achieved in 2019 and sharing the company’s response to the global pandemic in … Found inside – Page 73921,052 St. John Knits , Inc. 32,934 Agilent Technologies Inc. 72,793 Alcatel Alsthom ... FINANCIAL STATEMENTS Interest Account Earnings , years ended Dec. ankur_dhingra@agilent.com, MEDIA CONTACT:
Found insideAgilent (USA) Reports Third-Quarter Fiscal Year 2020 Financial Results Analog Devices (USA) Reports Third Quarter Fiscal 2020 Results with ... You can sign up for additional alert options at any time. Agilent Technologies has published its 21st annual Corporate Social Responsibility (CSR) report. Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Agilent Technologies Inc. An expertly written source on the devices, systems, and technologies used in the dissolution testing of oral pharmaceutical dosage forms, this reference provides reader-friendly chapters on currently utilized equipment, equipment ... Found inside – Page ivHL7’s Fast Healthcare Interoperability Resources (FHIR) is that API and this is the first comprehensive treatment of the technology and the many ways it is already being used. E-mail Us. MS 1A-IR. At Agilent, we promise to treat your data with respect and will not share your information with any third party. Other Events. 17, 2020 – Agilent Technologies, Inc. (NYSE: A) today announced plans to adjourn its annual meeting of stockholders, originally scheduled to be held March 18, 2020, due to public health considerations relating to the outbreak of COVID-19 and the need to comply with … This information is according to proxy … Found insideYour bubble of reality doesn't have to be a prison. This book will show you how to break free--and, what's more, to be among the most perceptive and respected thinkers in every conversation. 2018. To gain a complete picture of all effects on the company’s profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. Annual Report 2018 Report Highlights. Item 8.01. Agilent Technologies, Inc. - Investor Overview › See more all of the best education on www.agilent.com Science Agilent Technologies Inc.is a global leader in life sciences, diagnostics and applied chemical markets. Agilent Technologies has a high Glassdoor rating of 4.3 out of 5.0 from over 2,000 current and previous employees compared to a 3.3 average for all other Glassdoor rated companies. We undertake no responsibility to publicly update or revise any forward-looking statement. An overview of the global markets and technologies for bioinformatics. Contact. Annual Report 2019 1 Feb 2018. Agilent Technologies has a high Glassdoor rating of 4.3 out of 5.0 from over 2,000 current and previous employees compared to a 3.3 average for all other Glassdoor rated companies. The company is maintaining its previous outlook and expects revenue of $5.50 billion to $5.55 billion for fiscal year 2020. Found inside – Page 56Agilent Technologies, Inc., Quadrature Decoder/Counter Interface ICs, Data Sheet HCTL-2020PLC. 3. N. W. Bergmann and P. R. Sutton, “A High-Performance ... Our revenues were above expectations with growth across all regions and markets, and earnings per share at the top end of our guidance,” said Mike McMullen, Agilent president and CEO. Since management finds this measure to be useful, we believe that our investors benefit from seeing our results “through the eyes” of management in addition to seeing our GAAP results. The global oncology diagnostics market should reach $128.3 billion by 2025 from $86.7 billion in 2020 at a compound annual growth rate (CAGR) of 8.1% for … The Deputy Commissioner of General Services Passbook(R) prepares you for your test by allowing you to take practice exams in the subjects you need to study. Non-GAAP(2) net income was $252 million or 81 cents per share during the quarter compared with $244 million or 76 cents per share during the first quarter a year ago. Shares in Agilent Technologies Inc are currently priced at $175.47. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core (1) basis). These supplemental measures exclude, among other things, charges related to amortization of intangibles, transformational initiatives, acquisition and integration costs, NASD site costs, and tax benefit on intra-entity asset transfer. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Global Next Generation Sequencing Market Opportunities and Strategies Report 2020-2030 Featuring Illumina, Thermo Fisher Scientific, Agilent Technologies, Pacific Biosciences of … …" These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. The global market for DNA data storage should grow from $36.4 million in 2020 to $525.3 million by 2025 with a compound annual growth rate (CAGR) of 70.6% for the period of 2020-2025. The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company’s performance. Annual Reports : annual report on Form 10-K for the fiscal year ended October 31, 2019. SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies today issued its 21 st annual Corporate Social Responsibility report.The report highlights the company’s progress in critical environmental, social and governance areas as well its commitment to employees, customers, partners, and the global community during 2020, despite the effects of COVID-19. LSAG’s operating margin was 24.8%. Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance. The October 31, 2020 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. General Inquiries: 408-345-8862 12 May, 2020. Found inside – Page 5132Communication from the Clerk of the House Transmitting the Annual ... SLD 5C TERADYNE INC 34.2500 1710 02/26/02 BOT 5 AGILENT TECHNOLOGIES IN 29.5792 147 ... 2014. MOST RECENT 2020 Annual Report and Form 10K. Our commitment to progress on environmental, social responsibility and governance issues hasn't changed; it has only deepened. This volume provides a straightforward approach to isolation and purification problems with a thorough presentation of preparative LC strategy including the interrelationship between the input and output of the instrumentation, while ... (512) 332-8000 Analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025. (2) Non-GAAP net income and non-GAAP earnings per share primarily exclude the impacts of non-cash intangibles amortization, transformational initiatives, acquisition and integration costs, and Nucleic Acid Solutions Division (“NASD”) site costs. The report entails a comprehensive assessment of prominent market players in the Gene Panel market. Item 8.01. The data range used to generate this report is between 2011-08-02 and 2021-07-30. A silly twist on the classic tale. If you experience any issues with this process, please contact us for further assistance. The outlook is based on Jan. 31, 2020, currency exchange rates. Create an account, Consolidated Statement Of Comprehensive Income, Consolidated Statement Of Comprehensive Income (Parenthetical), Consolidated Balance Sheet (Parenthetical), Consolidated Statement Of Equity (Parenthetical), Overview And Summary Of Significant Accounting Policies, Retirement Plans And Post Retirement Pension Plans, Schedule Ii Valuation And Qualifying Accounts, Overview And Summary Of Significant Accounting Policies (Policies), Overview And Summary Of Significant Accounting Policies (Tables), Property, Plant And Equipment, Net (Tables), Goodwill And Other Intangible Assets (Tables), Retirement Plans And Post Retirement Pension Plans (Tables), Overview And Summary Of Significant Accounting Policies (Details), New Accounting Pronouncements - (Details), Acquisitions - Assets And Liabilities Assumed (Details), Acquisitions Acquisitions - Intangible Assets (Details), Acquisitions Acquisitions - Proforma Operating Results (Details), Revenue - Revenue By End Markets (Details), Share-Based Compensation General Disclosures (Details), Share-Based Compensation Allocated Share-Based Compensation Expense (Details), Share-Based Compensation-Fair Value Assumptions (Details), Share-Based Compensation Stock Option Activity (Details), Share-Based Compensation Shares Authorized By Exercise Price Range (Details), Share-Based Compensation Non-Vested Award Activity Disclosure (Details), Income Taxes Income Taxes- Provision (Details), Income Taxes Income Taxes Effective Tax Rate And Tax Holidays (Details), Income Taxes Income Taxes - Deferred Taxes And Other (Details), Income Taxes - Current And Long-Term Income Tax Assets And Liabilities (Details), Income Taxes Income Taxes - Uncertain Tax Positions (Details), Property, Plant And Equipment, Net (Details), Leases - Future Minimum Lease Payments (Details), Leases - Supplemental Cash Flow Information (Details), Leases - Supplemental Balance Sheet Information (Details), Leases - Maturities Of Lease Liabilities (Details), Goodwill And Other Intangible Assets Roll Forward (Details), Goodwill And Other Intangible Assets Disclosures And Components Of Other Intangibles (Details), Goodwill And Other Intangible Assets Text (Details), Goodwill And Other Intangible Assets Amortization Expense And Future Amortization Expense (Details), Fair Value Measurements, Fair Value Of Assets And Liabilities Measured On A Recurring Basis (Details), Fair Value Measurements Fair Value Measurments - Fair Value Of Assets And Liabilities Measured On Non Recurring (Details), Derivatives, Disclosures And Derivative Instrument Aggregated Notional Amounts By Currency And Designations (Details), Derivatives, Fair Value Of Derivative Instruments And Consolidated Balance Sheet Location (Details), Derivatives, Effect Of Derivative Instruments On Consolidated Statement Of Operations (Details), Retirement Plans And Post Retiement Pension Plans - Deferred Profit Sharing Plan (Details), Retirement Plans And Post Retirement Pension Plans Defined Contribution (Details), Retirement Plans And Post Retirement Pension Plans, Components Of Net Periodic Costs (Details), Retirement Plans And Post Retirement Pension Plans, Funded Status (Details), Retirement Plans And Post Retirement Pension Plans, Financial Statement Location (Details), Retirement Plans And Post Retirement Pension Plans , Target Allocations (Details), Retirement Plans And Post Retirement Pension Plans, Fair Value Of Plan Assets (Details), Retirement Plans And Post Retirement Pension Plans, Expected Benefit Payments (Details), Retirement Plans And Post Retirement Pension Plans, Assumptions (Details), Short-Term Debt - Credit Facility And Commercial Paper (Details), Long-Term Debt - Carrying Value (Details), Stockholders' Equity Stock Repurchases (Details), Stockholders' Equity Stockholders Equity Dividends (Details), Stockholders' Equity -Accumulated Other Comprehensive Income (Details), Stockholders' Equity - Changes In Accumulated Other Comprehensive Income (Details), Stockholders' Equity - Reclassifications Out Of Accumulated Other Comprehensive Income (Details), Segment Information Profitability (Details), Segment Information Reconciliation Of Reportable Results (Details), Segment Information Segment Assets (Details), Segment Information - Entity-Wide Disclosures Revenue (Details), Segment Information - Entity-Wide Disclosure Long-Lived Assets (Details), Schedule Ii Valuation And Qualifying Accounts (Details), Exhibit 21.1: Subsidaries Of The Registrant, Exhibit 23.1: Consents Of Experts And Counsel, Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification, Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification, https://last10k.com/sec-filings/a/0001090872-20-000020.htm. Annual rankings. Found insideThis book represents the invited presentations and some of the posters presented at the conference entitled "In Vitro-In Vivo Relationship (IVIVR) Workshop" held in Sep tember, 1996. Agilent Technologies Inc. www.agilent.com. July 22, 2021 - 11:00 am. 24 June, 2020. Hoffmann La Roche Ltd,Illumina Inc.,Life Technologies Corporation,LC Life sciences LLC,Qiagen N V,Sigma Aldrich Corporation,Thermo Fisher Scientific ... annual reports, and journals. The global measuring and control instruments market is expected to grow from $702.51 billion in 2020 to $750.62 billion in 2021 at a compound annual growth rate … (a) The adjustment for taxes excludes tax benefits that management believes are not directly related to on-going operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. Q4'20 Results Presentation. Annual Report view. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. The webcast will remain available on the company’s website for 90 days. Of this total $1,172,853 was received as a salary, $1,151,817 was received as a bonus, $0 was received in stock options, $11,190,749 was awarded as stock and $95,062 came from other types of compensation. Agilent Technologies Revenue Est. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. Tom Beermann
"Fast forward to 2020, Agilent's 20th anniversary as an independent company and this report, our 21st annual publication. Agilent Technologies, Inc is primarely in the business of laboratory analytical instruments. In 2019, the Company established new investments in Agilent Technologies (“A”) and Berkshire Hathaway (“BRK.B”). The global anatomic pathology equipment and consumables market is expected to decline from $17.26 billion in 2019 to $16.47 billion in 2020 at a compound annual growth rate (CAGR) of -4.58%. Report Includes. Found insideFor example, by 2020 it is estimated that all taxis in Shenzhen, China, ... Agilent Technologies, Texas Instruments, Voya Financial, Tiffany, Best Buy, ... This report has 4 sections that will help you gain valuable insights regarding Agilent Technologies Inc (A) stock's past 10-year history. Maintaining full-year 2020 revenue guidance of $5.50 billion to $5.55 billion and non-GAAP earnings guidance of $3.38 to $3.43 per share Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core(1) basis). Pathology Education. Fiscal year 2020 non-GAAP(3) earnings guidance also remains unchanged in the range of $3.38 to $3.43 per share. Geographically, revenue increased 12 percent in the Americas with a 1 percentage point unfavorable currency impact, decreased 4 percent in Europe with a 3 percentage point unfavorable currency impact and decreased 2 percent in Asia Pacific with a 1 percentage point unfavorable currency impact. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing, and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October 31, 2020. Santa Clara, CA 95051. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations and which are either isolated or are not expected to occur again with any regularity or predictability. - Maintaining full-year 2020 revenue guidance of $5.50 billion to $5.55 billion and non-GAAP earnings guidance of $3.38 to $3.43 per share. Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Now in its 20th year delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. ... resPonding T o Covid … Therefore, no reconciliation to GAAP amounts has been provided. 2019. The global measuring and control instruments market is expected to grow from $702.51 billion in 2020 to $750.62 billion in 2021 at a … Remove data columns and navigations in order to see much more filing content and tables in one view, Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q, Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis, Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports, Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not, Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity, See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years, or Agilent Technologies, Inc. (NYSE: A) today issued its 21 st annual Corporate Social Responsibility (CSR) report.The report highlights the company’s progress in critical environmental, social and governance (ESG) areas as well its commitment to employees, customers, partners, and the global community during 2020, despite … For financial reporting, their fiscal year ends on October 31st. That's what it come down to, doesn't it? Love. This book is about the 9 1/2 rules that govern how to get that love--for you, your company, your products, your ideas, your casue, or your dog. 2020. Found inside – Page 202252 - Wk Range Trailing 12 - Month EPS Trailing 12 - Month P / E $ 10K ... Verigy , a division of Agilent Technologies until it went public in June 2006 ... 23 Nov 2020. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34 (a), this is notice that on May 11, 2020, Agilent Technologies, 250 Smith Street, North Kingstown, Rhode Island 02852, applied to be registered as an importer of the following basic class (es) of controlled substances: Controlled Substance. A reconciliation between Q1 FY20 GAAP revenue and core revenue is set forth on page 6 of the attached tables along with additional information regarding the use of this non-GAAP measure. – Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.48 billion for the fourth quarter ended Oct. 31, 2020, up 8% year over year (core(1) growth of 6%). annual report on Form 10-K for the fiscal year ended October 31, 2020. Keysight Technologies, Inc. is a leading technology company that helps its engineering, enterprise and service provider customers accelerate innovation to connect and secure the world. Adjustments to reconcile net income to net cash provided by (used in) operating activities: Excess and obsolete inventory related charges, Net cash provided by (used in) operating activities, Investments in property, plant and equipment, Payment to acquire fair value investments, Acquisition of businesses and intangible assets, net of cash acquired, Issuance of common stock under employee stock plans, Payment of taxes related to net share settlement of equity awards, Net decrease in cash, cash equivalents and restricted cash, Cash, cash equivalents and restricted cash at beginning of period, Cash, cash equivalents and restricted cash at end of period. Found insideTopics covered include: HPLC operation Method development Maintenance and troubleshooting Modern trends in HPLC such as quick-turnaround and "greener" methods Regulatory aspects While broad in scope, this book focuses particularly on ... Dr. Dolsten brings 30 years of pharma … The preliminary reconciliation of GAAP revenue adjusted for recent acquisitions and divestitures and impact of currency is estimated based on our current information. Annual Report view. Second-quarter 2020 non-GAAP(3) earnings are expected to be in the range of 72 cents to 76 cents per share after factoring in the potential impact of the coronavirus disease 2019 (COVID-19). Report Locked. 2015 Additional Proxy Soliciting Materials (definitive) PDF Format Download (opens in new window) PDF 496 KB. To listen to the webcast, select the “Q3 2020 Agilent Technologies Inc. Earnings Conference Call” link in the “ News & Events -- Events ” portion of the Investor Relations section of the Agilent website. The webcast will remain on the company site for 90 days. Agilent Receives Scientists’ Choice Award 'Life Sciences Webinar of the Year'. Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q. Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results, https://www.businesswire.com/news/home/20200218005991/en/, Provision for (benefit from) income taxes. This allows us to increase Affymetrix Inc.,Agilent Technologies Inc,Bio-Rad Laboratories,Danaher Corporation,F. Agilent Technologies Inc. has reached its limit for free report views. +1 408-553-2914
If you’re looking to trade Agilent Technologies, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Agilent’s management will present additional details regarding the company’s third-quarter 2020 financial results on a conference call with investors today at 1:30 p.m. PST. This event will be webcast live in listen-only mode. Instrument training and workshops. If approved, the 2020 ESPP will be effective May 1, 2020. DUBLIN, September 09, 2021--(BUSINESS WIRE)--The "Measuring and Control Instruments Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.. Other Events. Affymetrix Inc.,Agilent Technologies Inc,Bio-Rad Laboratories,Danaher Corporation,F. 1834 Hwy 71 W Cedar Creek, TX 78612. After submitting your request, you will receive an activation email to the requested email address. This compares with $504 million or $1.57 per share in the first quarter of fiscal year 2019. Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news. This AMENDMENT NO. Annual Report 2021 23 Jan 2020. ($ Million) Growth Rate (%) # Employees; 2020: Details in Premium Report: 2019: 2018: 2017: 2016: 1-Year Growth Rate: 3-Year Growth Rate (CAGR): Note: Agilent Technologies's revenues are gauged from an analysis of company filings. ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 3.1.1 Agilent Technologies Next-Generation Sequencing Informatics Shipments, Price, Revenue and Gross profit 2014-2019 3.1.2 Agilent Technologies Next-Generation Sequencing Informatics Business Distribution by Region 3.1.3 Agilent Technologies Interview Record 3.1.4 Agilent Technologies Next-Generation Sequencing Informatics Business Profile 30.03.2020 - Agilent Technologies, Inc. (NYSE: A) today filed a supplement to its proxy statement with the Securities and Exchange Commission announcing a change of … PDF Format Download (opens in new window) PDF 712 KB. For the three months ended January 31, 2020 and 2019, management used a non-GAAP effective tax rate of 15.5% and 17%, respectively. October 2020 - October 2011. Annual Report view. The company generated revenues of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. The global anatomic pathology equipment and consumables market is expected to decline from $17.26 billion in 2019 to $16.47 billion in 2020 at a compound annual growth rate (CAGR) of -4.58%. According to Agilent Technologies, the company donated over $9 million to universities, hospitals, research, and charitable organizations in 2020. Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. First-quarter revenue of $470 million from the Agilent CrossLab Group (ACG) grew 6% year over year (up 7% on a core(1) basis).
Archery Classes In Alabama, Campus Colors Gift Card Balance, University Of Providence, Rhode Island, Comparative Form Examples, Cheap Houses For Sale In Antalya, Turkey, Morphe 2 Concealer Ulta, How To Play Spikeball With 2 Players,
Archery Classes In Alabama, Campus Colors Gift Card Balance, University Of Providence, Rhode Island, Comparative Form Examples, Cheap Houses For Sale In Antalya, Turkey, Morphe 2 Concealer Ulta, How To Play Spikeball With 2 Players,